219 related articles for article (PubMed ID: 28476435)
21. Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy.
Panje CM; Höng L; Hayoz S; Baracos VE; Herrmann E; Garcia Schüler H; Meier UR; Henke G; Schacher S; Hawle H; Gérard MA; Ruhstaller T; Plasswilm L;
Radiat Oncol; 2019 Sep; 14(1):166. PubMed ID: 31511012
[TBL] [Abstract][Full Text] [Related]
22. [Esophageal cancer: outcome according to therapeutic strategy].
Rousseau D; Capitain O; Denis F; Girault S; Poirier AL; Paumier A; Cellier P; Hamy A; Mahé MA; Mesgouez-Nebout N
Cancer Radiother; 2013 Feb; 17(1):10-20. PubMed ID: 23270680
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of trimodality CROSS regimen in older adults with locally advanced esophageal cancer.
Cooper L; Dezube AR; De León LE; Kucukak S; Mazzola E; Dumontier C; Mamon H; Enzinger P; Jaklitsch MT; Frain LN; Wee JO
Eur J Surg Oncol; 2021 Oct; 47(10):2667-2674. PubMed ID: 33895020
[TBL] [Abstract][Full Text] [Related]
24. Definitive Chemoradiation Therapy for Esophageal Cancer in the Elderly: Clinical Outcomes for Patients Exceeding 80 Years Old.
Xu C; Xi M; Moreno A; Shiraishi Y; Hobbs BP; Huang M; Komaki R; Lin SH
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):811-819. PubMed ID: 28602412
[TBL] [Abstract][Full Text] [Related]
25. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.
Wang SL; Liao Z; Vaporciyan AA; Tucker SL; Liu H; Wei X; Swisher S; Ajani JA; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):692-9. PubMed ID: 16242257
[TBL] [Abstract][Full Text] [Related]
26. Do elderly patients experience increased perioperative or postoperative morbidity or mortality when given neoadjuvant chemoradiation before esophagectomy?
Fogh SE; Yu A; Kubicek GJ; Scott W; Mitchell E; Rosato EL; Berger AC
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1372-6. PubMed ID: 21106309
[TBL] [Abstract][Full Text] [Related]
27. Validation of a Nomogram Predicting Survival After Trimodality Therapy for Esophageal Cancer.
Goense L; Merrell KW; Arnett AL; Hallemeier CL; Meijer GJ; Ruurda JP; Hofstetter WL; van Hillegersberg R; Lin SH
Ann Thorac Surg; 2018 Nov; 106(5):1541-1547. PubMed ID: 29932887
[TBL] [Abstract][Full Text] [Related]
28. Esophagectomy Timing After Neoadjuvant Therapy for Distal Esophageal Adenocarcinoma.
Franko J; Voynov G; Goldman CD
Ann Thorac Surg; 2016 Mar; 101(3):1123-30. PubMed ID: 26652139
[TBL] [Abstract][Full Text] [Related]
29. Does timing of esophagectomy following neoadjuvant chemoradiation affect outcomes? A meta-analysis.
Qin Q; Xu H; Liu J; Zhang C; Xu L; Di X; Zhang X; Sun X
Int J Surg; 2018 Nov; 59():11-18. PubMed ID: 30261331
[TBL] [Abstract][Full Text] [Related]
30. Utilization of surgery in trimodality-eligible patients with locally advanced esophageal adenocarcinoma in a nonprotocol setting.
Murphy CC; Hofstetter WL; Correa AM; Ajani JA; Komaki RU; Swisher SG
Dis Esophagus; 2013; 26(7):708-15. PubMed ID: 23350713
[TBL] [Abstract][Full Text] [Related]
31. Trimodality therapy for esophageal cancer at high volume facilities is associated with improved postoperative outcomes and overall survival.
Haque W; Verma V; Butler EB; Teh BS
Dis Esophagus; 2019 Apr; 32(4):. PubMed ID: 30052835
[TBL] [Abstract][Full Text] [Related]
32. [Long-term outcome of neoadjuvant radiochemotherapy followed by surgery for esophageal cancer: a single institution retrospective study of 102 patients].
Ruffier-Loubière A; Janoray G; Chapet S; de Calan L; Dumont P; Dorval É; Orain I; Calais G
Cancer Radiother; 2015 Aug; 19(5):322-30. PubMed ID: 26215366
[TBL] [Abstract][Full Text] [Related]
33. NTCP model for postoperative complications and one-year mortality after trimodality treatment in oesophageal cancer.
Thomas M; Defraene G; Lambrecht M; Deng W; Moons J; Nafteux P; Lin SH; Haustermans K
Radiother Oncol; 2019 Dec; 141():33-40. PubMed ID: 31630867
[TBL] [Abstract][Full Text] [Related]
34. Effects of neoadjuvant chemoradiotherapy on postoperative morbidity and mortality associated with esophageal cancer.
Hamai Y; Hihara J; Taomoto J; Yamakita I; Ibuki Y; Okada M
Dis Esophagus; 2015; 28(4):358-64. PubMed ID: 24612033
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.
Kim MS; Lim JS; Hyung WJ; Lee YC; Rha SY; Keum KC; Koom WS
World J Gastroenterol; 2015 Mar; 21(9):2711-8. PubMed ID: 25759540
[TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
[TBL] [Abstract][Full Text] [Related]
37. Multimodal treatment of locally advanced esophageal adenocarcinoma: which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients.
Hoeppner J; Zirlik K; Brunner T; Bronsert P; Kulemann B; Sick O; Marjanovic G; Hopt UT; Makowiec F
J Surg Oncol; 2014 Mar; 109(3):287-93. PubMed ID: 24277235
[TBL] [Abstract][Full Text] [Related]
38. Comparative outcomes for three-dimensional conformal versus intensity-modulated radiation therapy for esophageal cancer.
Freilich J; Hoffe SE; Almhanna K; Dinwoodie W; Yue B; Fulp W; Meredith KL; Shridhar R
Dis Esophagus; 2015; 28(4):352-7. PubMed ID: 24635657
[TBL] [Abstract][Full Text] [Related]
39. Using the Comprehensive Complication Index to Assess the Impact of Neoadjuvant Chemoradiotherapy on Complication Severity After Esophagectomy for Cancer.
Nederlof N; Slaman AE; van Hagen P; van der Gaast A; Slankamenac K; Gisbertz SS; van Lanschot JJ; Wijnhoven BP; van Berge Henegouwen MI;
Ann Surg Oncol; 2016 Nov; 23(12):3964-3971. PubMed ID: 27301849
[TBL] [Abstract][Full Text] [Related]
40. Sex Disparities After Induction Chemoradiotherapy and Esophagogastrectomy for Esophageal Cancer.
Rowse PG; Jaroszewski DE; Thomas M; Harold K; Harmsen WS; Shen KR
Ann Thorac Surg; 2017 Oct; 104(4):1147-1152. PubMed ID: 28842111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]